Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe

Ming Chen1, Lixin Wan2,3, Jiangwen Zhang4

  • 1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Nature Communications
|January 17, 2018
PubMed

Insights

Genomic amplification of PPP1CA gene drives metastatic prostate cancer by activating the MAPK pathway. The PML tumor suppressor counteracts this by sequestering PP1α, revealing a key cancer-driving molecular network.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Mitogen-activated protein kinase (MAPK) pathway hyperactivation is common in advanced cancers like metastatic prostate cancer (CaP).
  • Mechanisms of MAPK activation in cancers lacking Ras/Raf mutations are not fully understood.
  • Genomic alterations in MAPK pathway components are not always the cause of its aberrant activation.

Purpose of the Study:

  • To investigate novel mechanisms of MAPK pathway activation in metastatic prostate cancer.
  • To identify genetic alterations and signaling pathways contributing to MAPK hyperactivation.
  • To elucidate the role of the PML tumor suppressor in regulating MAPK signaling.

Main Methods:

  • Genomic analysis to identify enriched gene amplifications in metastatic CaP.
  • Signal transduction pathway analysis involving S6K, PP1α, B-Raf, and MAPK.
  • Investigation of protein-protein interactions and subcellular localization (PML nuclear bodies).

Main Results:

  • Genomic amplification of the PPP1CA gene is significantly enriched in metastatic human CaP.
  • An S6K/PP1α/B-Raf signaling cascade was identified, leading to MAPK activation.
  • PML tumor suppressor antagonizes MAPK activation by sequestering PP1α in nuclear bodies, preventing its activation.

Conclusions:

  • PP1α acts as a B-Raf activating phosphatase, crucial for MAPK pathway activation.
  • PML suppresses MAPK signaling by inhibiting PP1α phosphorylation and cytoplasmic accumulation.
  • The PP1α/PML molecular network is a novel, genetically altered pathway in cancer, offering therapeutic targets.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.2K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.6K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.2K